Olean Times Herald

BRUSSELS , April 3, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neur...

ATLANTA , March 12, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from the final ana...

ATLANTA , March 7, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced two-year data from the BE HEARD^ trials for BIMZELX ®...

ATLANTA , Feb. 27, 2025 /PRNewswire/ -- UCB Full-Year Report 2024, Brussels ( Belgium ) – regulated information Jean-Christophe Tellier , CEO UCB says...

ATLANTA , Jan. 16, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and au...